Jump to content

Recommended Posts

  • Chief Cushie
Posted

http://www.acurian.com/patient....lcthtml

 

Summary: Hypopituitary Control and Complications Study

Dr. Stanley Korenman of UCLA's Division of Endocrinology is conducting a study to look at the effects of the long-term use of Growth Hormone Therapy (Humatrope, an FDA approved medication). The study involves measurements of blood levels of hormones, bone density and body fat every 6 months for 5 years (a total of 11 visits).

 

Study Criteria:

 

Be over 18 years of age

Have known pituitary disease, either as a child or as a result of pituitary tumors

Be taking hormone replacement

Have health insurance

Be interested in Growth Hormone Therapy

 

Contact:

 

Care Felix, Clinical Research Coordinator

UCLA Medical Center

Office of Clinical Trials

10900 Wilshire Blvd, Suite 170

Los Angeles, CA 90024

Telephone: 310-794-8900

Fax: 310-794-8902

Email: [email protected]

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...